Mabion S.A. (WSE:MAB)
Poland
· Delayed Price · Currency is PLN 8.05
-0.01 (-0.12%)
Mar 6, 2026, 5:00 PM CET
Mabion Employees
As of December 31, 2024, Mabion had 213 total employees, including 206 full-time and 7 part-time employees. The number of employees decreased by 34 or -13.77% compared to the previous year.
Employees
213
Change (1Y)
-34
Growth (1Y)
-13.77%
Revenue / Employee
70.53K PLN
Profits / Employee
-282.37K PLN
Market Cap
130.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 213 | -34 | -13.77% |
| Dec 31, 2023 | 247 | -8 | -3.14% |
| Dec 31, 2022 | 255 | 11 | 4.51% |
| Dec 31, 2021 | 244 | 31 | 14.55% |
| Dec 31, 2020 | 213 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Poltreg | 33 |
| Molecure | 71 |
| Urteste | 36 |
| Synthaverse | 239 |
| BIOTON | 364 |
| Bioceltix | 41 |
| Pharmena | 7 |
| Captor Therapeutics Spolka Akcyjna | 91 |
Mabion News
- 5 years ago - Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as Chief Technical Officer - GlobeNewsWire
- 5 years ago - Spark Therapeutics Announces First Participant Dosed in Phase 1/2 Study of Investigational Gene Therapy for Late-Onset Pompe Disease - GlobeNewsWire
- 6 years ago - GAMCO Investors Exits Viacom, Spark Therapeutics - GuruFocus
- 6 years ago - Regulators Give Roche Green Light For $4.3B Spark Therapeutics Acquisition - Benzinga
- 6 years ago - Roche to complete $4.3 billion Spark deal as regulators give all clear - Reuters
- 6 years ago - U.S. antitrust enforcers give Roche approval to buy Spark Therapeutics - Reuters
- 6 years ago - Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product - GlobeNewsWire
- 6 years ago - FTC staff recommends approval of Roche deal for Spark: report - Reuters